$7.03 -0.21 (-2.90%)
11/20/2009 4:00 PM

Jazz Pharmaceuticals, Inc. (JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Featured Broker Partners